Top-News

Clinigen Group News

Keine aktuellen Kursdaten verfügbar
WKN: A1J440
ISIN: GB00B89J2419
US-Symbol: CLIGF
Typ: Aktie

Clinigen Group News

25.01.22 - DGAP
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Maitland Institutional Services Limited (MISL) Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV 25-Jan-2022 / 15:02 GMT/BST Dissemination of a ...
25.01.22 - DGAP
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Maitland Institutional Services Limited (MISL) Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV 25-Jan-2022 / 14:56 GMT/BST Dissemination of a ...
17.12.21 - DGAP
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Maitland Institutional Services Limited (MISL) Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV 17-Dec-2021 / 16:59 GMT/BST Dissemination of a ...
14.12.21 - DGAP
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Maitland Institutional Services Limited (MISL) Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV 14-Dec-2021 / 14:49 GMT/BST Dissemination of a ...
09.12.21 - DGAP
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group plc
Maitland Institutional Services Limited (MISL) Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group plc 09-Dec-2021 / 14:40 GMT/BST Dissemination of a Regulatory ...
08.12.21 - DGAP
Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Clinigen Group plc
Maitland Institutional Services Limited (MISL) Form 8.3 - Maitland Institutional Services Limited: Form 8.3 - Clinigen Group plc 08-Dec-2021 / 13:52 GMT/BST Dissemination of a ...
06.12.21 - DGAP
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Maitland Institutional Services Limited (MISL) Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV 06-Dec-2021 / 13:27 GMT/BST Dissemination of a ...
03.12.21 - DGAP
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc: Opening Position Disclosure
Maitland Institutional Services Limited (MISL) Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc: Opening Position Disclosure 03-Dec-2021 / 14:19 GMT/BST ...
25.09.17 - PR Newswire
Cumberland Pharmaceuticals Launches Promotion of Totect® in The U.S. for Emergency Oncology Intervention
Cumberland Pharmaceuticals Launches Promotion of Totect® in The U.S. for Emergency Oncology Intervention PR Newswire
18.09.14 - PR Newswire
Neues Antibiotikum VIBATIV®▼ (Telavancin), welches gezielt für die Priorität des öffentlichen Gesundheitswesens, nämlich MRSA-Infektionen bei Menschen mit im Krankenhaus erworbener Pneunomie, eingeset
Neues Antibiotikum VIBATIV®▼ (Telavancin), welches gezielt für die Priorität des öffentlichen Gesundheitswesens, nämlich MRSA-​Infektionen bei Menschen mit im Krankenhaus ...
18.09.14 - PR Newswire
New Antibiotic VIBATIV®▼ (telavancin) Targets Public Health Priority MRSA Infections for People with Hospital-Acquired Pneumonia Across Europe
New Antibiotic VIBATIV®▼ (telavancin) Targets Public Health Priority MRSA Infections for People with Hospital-​Acquired Pneumonia Across Europe PR Newswire

Newssuche

Videos

newspaper
18.04.24
Technical Trading: Gold mit weiterem Potenzial
Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »